Dr. James Feusner, MD

Dr. Mark Walters, MD, is a pediatric hematologist-oncologist specializing in the care of children with blood disorders and cancer, particularly focusing on blood and bone marrow transplants. He serves as the director of the Pediatric Blood and Marrow Transplant Program at UCSF Benioff Children's Hospital in Oakland, where he is dedicated to improving treatment outcomes for his patients. With a research emphasis on gene therapy for sickle cell disease and thalassemia, Dr. Walters aims to provide curative therapies and innovative solutions for his young patients. He holds a medical degree from the University of California, San Diego, and has completed extensive training in pediatrics and pediatric hematology-oncology. Generated from the website

Dr. Sylvia Singer, MD, is a pediatric hematologist-oncologist and the Director of Hemostasis and Thrombosis at UCSF Benioff Children's Hospital in Oakland, CA. With a focus on providing world-class care, she specializes in treating conditions related to blood disorders and cancer in children and young adults. Dr. Singer is an accomplished medical professional with a robust educational background, including her MD from Hebrew University and fellowships at UCSF. Her research contributions further enhance her expertise in the field, making her a valuable resource for families seeking specialized pediatric care. Generated from the website

Marsha Treadwell, PhD, is a psychologist based in Oakland, CA, specializing in the care of children and families affected by medical conditions, particularly sickle cell disease. She leads initiatives aimed at improving the quality of life and healthcare access for patients, while also focusing on resilience-building strategies for coping with stress related to medical treatments. With a doctorate in clinical child psychology from the University of Washington, Dr. Treadwell is dedicated to addressing health disparities and promoting diversity in medicine. Her extensive research spans multiple countries and aims to enhance the understanding and management of sickle cell disease through collaborative efforts among healthcare providers and policymakers. Generated from the website